BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23315892)

  • 1. Making the transition to a learning health care system. Commentary.
    Grady C; Wendler D
    Hastings Cent Rep; 2013; Spec No():S32-3. PubMed ID: 23315892
    [No Abstract]   [Full Text] [Related]  

  • 2. A prescription for ethical learning. Commentary.
    Largent EA; Miller FG; Joffe S
    Hastings Cent Rep; 2013; Spec No():S28-9. PubMed ID: 23315890
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in the research enterprise. Commentary.
    Kupersmith J
    Hastings Cent Rep; 2013; Spec No():S43-4. PubMed ID: 23315897
    [No Abstract]   [Full Text] [Related]  

  • 4. The unbelievable rightness of being in clinical trials. Commentary.
    Menikoff J
    Hastings Cent Rep; 2013; Spec No():S30-1. PubMed ID: 23315891
    [No Abstract]   [Full Text] [Related]  

  • 5. Reform within the common rule? Commentary.
    Puglisi T
    Hastings Cent Rep; 2013; Spec No():S40-2. PubMed ID: 23315896
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethical oversight: serving the best interests of patients. Commentary.
    Selby JV; Krumholz HM
    Hastings Cent Rep; 2013; Spec No():S34-6. PubMed ID: 23315893
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation as part of operations: reconciling the common rule and continuous improvement. Commentary.
    Platt R; Grossmann C; Selker HP
    Hastings Cent Rep; 2013; Spec No():S37-9. PubMed ID: 23315894
    [No Abstract]   [Full Text] [Related]  

  • 8. An ethics framework for a learning health care system: a departure from traditional research ethics and clinical ethics.
    Faden RR; Kass NE; Goodman SN; Pronovost P; Tunis S; Beauchamp TL
    Hastings Cent Rep; 2013; Spec No():S16-27. PubMed ID: 23315888
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethical oversight of research on patient care.
    Solomon MZ; Bonham AC
    Hastings Cent Rep; 2013; Spec No():S2-3. PubMed ID: 23315889
    [No Abstract]   [Full Text] [Related]  

  • 10. The research-treatment distinction: a problematic approach for determining which activities should have ethical oversight.
    Kass NE; Faden RR; Goodman SN; Pronovost P; Tunis S; Beauchamp TL
    Hastings Cent Rep; 2013; Spec No():S4-S15. PubMed ID: 23315895
    [No Abstract]   [Full Text] [Related]  

  • 11. Health researchers' ancillary care obligations in low-resource settings: how can we tell what is morally required?
    Merritt MW
    Kennedy Inst Ethics J; 2011 Dec; 21(4):311-47. PubMed ID: 22187929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vulnerability: a needed moral safeguard.
    DeMarco JP
    Am J Bioeth; 2004; 4(3):82-4; discussion W32. PubMed ID: 16192156
    [No Abstract]   [Full Text] [Related]  

  • 13. The gambler's fallacy, the therapeutic misconception, and unrealistic optimism.
    Swekoski D; Barnbaum D
    IRB; 2013; 35(2):1-6. PubMed ID: 23672144
    [No Abstract]   [Full Text] [Related]  

  • 14. Who is a patient and why does it matter?
    Iltis AS
    Am J Bioeth; 2011 May; 11(5):62-4. PubMed ID: 21534158
    [No Abstract]   [Full Text] [Related]  

  • 15. The two-patient framework for research during pregnancy: a critique and a better way forward.
    Liaschenko J; DeBruin D; Marshall MF
    Am J Bioeth; 2011 May; 11(5):66-8. PubMed ID: 21534160
    [No Abstract]   [Full Text] [Related]  

  • 16. Exploring the ethics and psychological impact of deception in psychological research.
    Boynton MH; Portnoy DB; Johnson BT
    IRB; 2013; 35(2):7-13. PubMed ID: 23672145
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the case for the regulation of research.
    Wilkinson T
    Am J Bioeth; 2010 Aug; 10(8):63-5. PubMed ID: 20694915
    [No Abstract]   [Full Text] [Related]  

  • 18. Time to stop worrying about the therapeutic misconception.
    Wendler DS
    J Clin Ethics; 2012; 23(3):272-87. PubMed ID: 23256408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fetus as a patient and the ethics of human subjects research: response to commentaries on "An ethically justified framework for clinical investigation to benefit pregnant and fetal patients".
    McCullough LB; Chervenak FA
    Am J Bioeth; 2011 May; 11(5):W3-7. PubMed ID: 21534136
    [No Abstract]   [Full Text] [Related]  

  • 20. Unacceptable risk in pregnancy: whose choice and responsibility?
    Perry C
    Am J Bioeth; 2011 May; 11(5):64-5. PubMed ID: 21534159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.